SecSonar.com

Pulmatrix, Inc. (PULM)

Pulmatrix, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Pulmatrix, Inc. (PULM) is a Biotechnology company based in US with a market capitalization of $5M. Free cash flow was negative at -$5.4M. This page tracks PULM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2 employees · IPO Mar 21, 2014

Valuation

Valuation & price

$1.25 · as of May 17, 2026 · -81.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.32

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$6.66$3.94$1.21Jul 25Dec 25Jul 26Jul 7, 25$6.66Jul 9, 25$6.51Jul 11, 25$6.31Jul 15, 25$6.16Jul 17, 25$6.33Jul 21, 25$6.07Jul 23, 25$6.02Jul 25, 25$5.62Jul 29, 25$5.27Jul 31, 25$5.63Aug 4, 25$5.41Aug 6, 25$5.31Aug 11, 25$5.00Aug 13, 25$4.65Aug 15, 25$4.71Aug 19, 25$4.62Aug 21, 25$4.47Aug 25, 25$4.97Aug 27, 25$4.86Aug 29, 25$4.93Sep 3, 25$4.65Sep 5, 25$4.87Sep 9, 25$4.77Sep 11, 25$4.99Sep 16, 25$5.09Sep 18, 25$4.90Sep 22, 25$4.85Sep 24, 25$4.56Sep 26, 25$4.43Sep 30, 25$4.86Oct 2, 25$4.87Oct 6, 25$5.06Oct 8, 25$4.93Oct 10, 25$4.77Oct 14, 25$4.90Oct 16, 25$4.64Oct 21, 25$4.94Oct 23, 25$4.85Oct 27, 25$4.93Oct 29, 25$4.88Oct 31, 25$4.93Nov 4, 25$4.77Nov 6, 25$4.78Nov 10, 25$4.83Nov 12, 25$4.88Nov 14, 25$4.71Nov 18, 25$4.50Nov 20, 25$4.67Nov 25, 25$4.32Nov 28, 25$4.45Dec 2, 25$4.43Dec 4, 25$4.27Dec 8, 25$4.01Dec 10, 25$3.95Dec 12, 25$4.58Dec 16, 25$4.10Dec 18, 25$3.72Dec 22, 25$2.47Dec 24, 25$2.29Dec 29, 25$2.22Jan 2, 26$2.26Jan 6, 26$2.30Jan 8, 26$2.35Jan 12, 26$2.35Jan 14, 26$2.37Jan 16, 26$2.63Jan 21, 26$2.63Jan 23, 26$2.66Jan 27, 26$2.61Jan 29, 26$2.62Feb 2, 26$2.59Feb 4, 26$2.57Feb 9, 26$2.46Feb 11, 26$2.38Feb 13, 26$2.44Feb 18, 26$2.62Feb 20, 26$2.84Feb 24, 26$3.33Feb 26, 26$2.91Mar 2, 26$1.89Mar 4, 26$2.16Mar 6, 26$2.02Mar 10, 26$2.23Mar 12, 26$2.16Mar 17, 26$2.11Mar 19, 26$2.15Mar 23, 26$2.26Mar 25, 26$2.12Mar 27, 26$1.36Mar 31, 26$1.29Apr 2, 26$1.31Apr 7, 26$1.26Apr 9, 26$1.26Apr 13, 26$1.21Apr 15, 26$1.25Apr 17, 26$1.26Apr 22, 26$1.40Apr 24, 26$1.35Apr 28, 26$1.28Apr 30, 26$1.26May 4, 26$1.31May 6, 26$1.36May 8, 26$1.30May 12, 26$1.25May 14, 26$1.27May 18, 26$1.26May 20, 26$1.27May 22, 26$1.34May 28, 26$1.38Jun 1, 26$1.39Jun 3, 26$1.29Jun 5, 26$1.33Jun 9, 26$1.38Jun 11, 26$1.38Jun 15, 26$1.41Jun 17, 26$1.50Jun 22, 26$1.54Jun 24, 26$1.53Jun 26, 26$1.64Jul 2, 26$1.72
$1.1952-week range$6.66
Loading valuation history…

Fundamentals

Key fundamentals

$5M

Market cap

—

Revenue growth (YoY)

8.2%

Gross margin

-$5.4M

Free cash flow (USD)

-$4.1M

Net debt

Net cash position

0.0%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$835.0KFY 2017$335.0KFY 2018$153.0KFY 2019$7.9MFY 2020$12.6MFY 2021$5.2MFY 2022$6.1MFY 2023$7.3MFY 2024$7.8MFY 2025$0.00
$835K$0

Free cash flow by year

2016 → 2025

FY 2016$-13.7MFY 2017$-14.6MFY 2018$-16.8MFY 2019$3.2MFY 2020$-12.8MFY 2021$-19.9MFY 2022$-19.4MFY 2023$-16.7MFY 2024$-11.1MFY 2025$-5.4M
-$13.7M-$5.4M

Gross margin by year

2021 → 2024

FY 2021-197.6%FY 2022-200.4%FY 2023-112.6%FY 20248.2%
-197.6%8.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.32)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual report10-K FiledJun 16, 2026Filing
  • FinancingSecurities RegistrationJun 4, 2026Filing
  • 8-K eventFirst Quarter 2026 ResultsMay 15, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventPrivate Placement ClosedApr 21, 2026Filing

Questions

Frequently asked questions

What is Pulmatrix, Inc.'s market cap?

Pulmatrix, Inc. (PULM) has a market capitalization of $5M.

What is PULM's P/E ratio?

A meaningful P/E ratio is not available for PULM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PULM's price-to-book (P/B) ratio?

PULM trades at 1.32 times book value per share.

When did Pulmatrix, Inc. last report earnings?

PULM last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying PULM stock?

SEC Form 4 filings show no open-market insider buys at Pulmatrix, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

BCAB

BioAtla, Inc.

$5M

CLGN

CollPlant Biotechnologies Ltd.

$5M

ADXN

Addex Therapeutics Ltd

$5M

APM

Aptorum Group Limited

$5.3M

BRTX

BioRestorative Therapies, Inc.

$4.6M

BCDA

BioCardia, Inc.

$5.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.